ATG5 and gastric cancer: Frameshift mutations in atg5 are common in gastric cancers with high MSI [45]. Absent in approximately one fifth of the gastric cancers [44], but is highly expressed in chemoresistant gastric cancer cells [72]. Associates with the shorter survival time in gastric cancer patients [72]